Startseite The crystal structure of C19H20O8
Artikel Open Access

The crystal structure of C19H20O8

  • Bao-Long Lai , Hai-Ming Zhou , Zan-Hong Chen , Hui-Ying Chen , Qin-Wen Zhang und Yi-Wen Tao ORCID logo EMAIL logo
Veröffentlicht/Copyright: 4. Januar 2022
Artikel downloaden (PDF)
Veröffentlichen auch Sie bei De Gruyter Brill
Manuskript einreichen Informationen für Autor*innen
Zeitschrift für Kristallographie - New Crystal Structures
Aus der Zeitschrift Zeitschrift für Kristallographie - New Crystal Structures Band 237 Heft 1

Abstract

C19H20O8, triclinic, P 1 ‾ (no. 2), a = 7.0708(4) Å, b = 8.1261(4) Å, c = 16.1067(6) Å, α = 81.252(4)°, β = 81.500(4)°, γ = 77.890(4)°, V = 887.88(8) Å3, Z = 2, R gt (F) = 0.0418, wRref(F2) = 0.1158, T = 150 K.

CCDC no.: 2125914

The crystal structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Block, colourless
Size: 0.14 × 0.12 × 0.1 mm
Wavelength: Cu Kα radiation (1.54184 Å)
μ: 0.94 mm−1
Diffractometer, scan mode: SuperNova, φ and ω-scans
θmax, completeness: 74°, >99%
N(hkl)measured, N(hkl)unique, Rint: 5703, 3448, 0.01
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 3217
N(param)refined: 252
Programs: CrysAlisPRO [1], SHELX [2, 3], OLEX2 [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z Uiso*/Ueq
O1 0.28517 (18) 0.09974 (14) 0.49229 (7) 0.0306 (3)
H1 0.318511 0.036168 0.455598 0.046*
O2 0.38647 (16) 0.51210 (13) 0.25448 (6) 0.0236 (3)
O3 0.36190 (17) 0.02077 (13) 0.34200 (7) 0.0290 (3)
O4 0.02217 (15) 0.37782 (14) 0.25178 (6) 0.0245 (3)
O5 0.72670 (15) 0.10598 (13) 0.24897 (7) 0.0261 (3)
O6 0.74456 (17) −0.09407 (14) 0.16472 (7) 0.0306 (3)
O7 0.61026 (16) 0.11270 (14) 0.01399 (7) 0.0269 (3)
O8 0.25843 (18) 0.29744 (15) −0.03545 (7) 0.0312 (3)
H8 0.314942 0.215291 −0.059214 0.047*
C1 0.3272 (2) 0.30330 (18) 0.36853 (9) 0.0200 (3)
C2 0.2894 (2) 0.26020 (19) 0.45730 (10) 0.0227 (3)
C3 0.2498 (2) 0.3838 (2) 0.51176 (10) 0.0256 (3)
H3 0.223409 0.353111 0.569684 0.031*
C4 0.2494 (2) 0.5520 (2) 0.48048 (10) 0.0246 (3)
C5 0.2940 (2) 0.59814 (19) 0.39370 (10) 0.0232 (3)
H5 0.296741 0.710901 0.372822 0.028*
C6 0.3340 (2) 0.47659 (18) 0.33881 (9) 0.0206 (3)
C7 0.3449 (2) 0.17365 (18) 0.31313 (9) 0.0202 (3)
C8 0.3325 (2) 0.21632 (17) 0.21981 (9) 0.0199 (3)
C9 0.4823 (2) 0.14568 (17) 0.16078 (9) 0.0206 (3)
C10 0.4630 (2) 0.17475 (18) 0.07444 (9) 0.0220 (3)
C11 0.2890 (2) 0.26826 (19) 0.04760 (9) 0.0231 (3)
C12 0.1398 (2) 0.34005 (18) 0.10547 (10) 0.0224 (3)
H12 0.025385 0.404527 0.086877 0.027*
C13 0.1620 (2) 0.31536 (18) 0.19082 (9) 0.0204 (3)
C14 0.6641 (2) 0.03803 (18) 0.19039 (9) 0.0216 (3)
C15 0.8868 (3) 0.0020 (2) 0.29061 (12) 0.0342 (4)
H15A 1.004143 −0.006154 0.251686 0.051*
H15B 0.859065 −0.109317 0.309234 0.051*
H15C 0.903369 0.052617 0.338518 0.051*
C16 0.2051 (2) 0.6858 (2) 0.53927 (11) 0.0307 (4)
H16A 0.324327 0.701926 0.555742 0.046*
H16B 0.122181 0.650514 0.588638 0.046*
H16C 0.140345 0.790551 0.510958 0.046*
C17 −0.1453 (2) 0.4931 (2) 0.22468 (11) 0.0306 (4)
H17A −0.105157 0.586860 0.187517 0.046*
H17B −0.227882 0.534055 0.273037 0.046*
H17C −0.215548 0.435839 0.195236 0.046*
C18 0.3681 (3) 0.6854 (2) 0.21888 (11) 0.0337 (4)
H18A 0.414300 0.691825 0.159579 0.051*
H18B 0.443894 0.740677 0.246618 0.051*
H18C 0.233743 0.740409 0.226462 0.051*
C19 0.7703 (3) 0.2003 (2) −0.00111 (11) 0.0356 (4)
H19A 0.861445 0.157026 −0.046706 0.053*
H19B 0.833769 0.183181 0.049097 0.053*
H19C 0.723024 0.319289 −0.015850 0.053*

Source of materials

Light yellow crystals of the title compound were obtained by slow evaporation in the methanol and dichloromethane solution in a ratio of 1:2 at 4 °C.

Experimental details

All hydrogen atoms were placed in calculated positions and refined using a riding model with the relative isotropic parameters.

Comment

Strain Aspergillus fumigatus was collected from Dongzhai Harbor, Hainan province, China, and identified by 18S RNA gene sequence. The specimen was stored at Guangzhou Medical University, Guangzhou, P. R. China. The stored strain was cultured and fermented on rice medium (sea salt 2 g/L, rice 350 g/L) at 28 °C for 30 days [5]. The fermentation was soaked in an equal volume of methanol. After being concentrated with a rotary evaporator, it was extracted with ethyl acetate. The ethyl acetate extract was repeatedly washed with methanol after drying. Methanol insoluble and methanol soluble portions were obtained afterwards. The methanol-insoluble substance was then identified as trypacidin. Trypacidin was added with 2 mL sodium hydroxide methanol solution (1 mol/L), stirred and reacted for 12 h at room temperature. The reaction was ended by adding formic acid to adjust pH value to neutrality, and then the products were further isolated and purified by silica gel chromatography using a solvent system of 2:1 CH2Cl2/MeOH to afford the title compound. Its crystals were obtained by being dissolved in mixed solvent of CH2Cl2/MeOH(2/1, v/v) and slowly evaporated at 4 °C.

The structure was clarified by comprehensive analysis of spectral data and confirmed by X-ray crystallography. Geometric parameters are all in the expected ranges. The title compound was named as asperfumin. Liu et al. [6] first purified, identified, and enumerated the 1H NMR and 13C NMR data of asperfumin with a benzophenone structure. Asperfumin is NRPS gene clusters dependent [7] and could inhibit the secretion of IL-6 and decrease collagen IV and fibronectin production at 10 μM in mesangial cells treated with high glucose. Moreover, it didn't exhibit cytotoxicity against mesangial cells at 10 μM using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazoliumbromide (MTT) assay [8].

Corresponding author: Yi-Wen Tao, Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 511436, P. R. China, E-mail:
Hai-Ming Zhou: Co-first author.

Funding source: Guangzhou Education Bureau Yangcheng Scholars Project

Award Identifier / Grant number: 202032774

Funding source: Scientific Research Foundation of Traditional Chinese Medicine of Health and Family Planning Bureau

Award Identifier / Grant number: GM2019020026

Funding source: National Students Training Programs for Innovation and Entrepreneurship

Award Identifier / Grant number: 202010570028

Funding source: Special Funds for Undergraduates’ Scientific and Technological Innovation Training Programs in Guangdong

Award Identifier / Grant number: pdjh2021b0417

Award Identifier / Grant number: pdjh2020b0487

Award Identifier / Grant number: S201910570075

Award Identifier / Grant number: S201910570069

Funding source: Undergraduate Training Programs for Innovation and Entrepreneurship in GZHMU

Award Identifier / Grant number: 2020A068

Award Identifier / Grant number: 2019A076

Award Identifier / Grant number: 2018A107

Award Identifier / Grant number: 2018A103

Funding source: High-level University Construction Fund of Guangdong Province

Award Identifier / Grant number: 06-410-2107242

Award Identifier / Grant number: 06-410-2107249

Award Identifier / Grant number: 06-410-2107273

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by Guangzhou Education Bureau Yangcheng Scholars Project (202032774), Scientific Research Foundation of Traditional Chinese Medicine of Health and Family Planning Bureau from Guangming District (GM2019020026), National Students Training Programs for Innovation and Entrepreneurship (202010570028), Special Funds for Undergraduates’ Scientific and Technological Innovation Training Programs in Guangdong (pdjh2021b0417, pdjh2020b0487, S201910570075, S201910570069), Undergraduate Training Programs for Innovation and Entrepreneurship in GZHMU (2020A068, 2019A076, 2018A107, 2018A103), and High-level University Construction Fund of Guangdong Province (06-410-2107242, 06-410-2107249, 06-410-2107273).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Oxford Diffraction Ltd. CrysAlisPRO: Abingdon, Oxfordshire, England, 2006.Suche in Google Scholar

2. Sheldrick, G. M. SHELXT - integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370.Suche in Google Scholar

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

4. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar

5. Zhang, J. Y., Lai, Z. Z., Huang, W. J., Ling, H. P., Lin, M. T., Tang, S. L., Liu, Y., Tao, Y. W. Apicidin inhibited proliferation and invasion and induced apoptosis via mitochondrial pathway in non-small cell lung cancer GLC-82 cells. Anti Cancer Agents Med. Chem. 2017, 17, 1374–1382; https://doi.org/10.2174/1871520617666170419120044.Suche in Google Scholar

6. Liu, J. Y., Song, Y. C., Zhang, Z., Wang, L., Guo, Z. J., Zou, W. X., Tan, R. X. Aspergillus fumigatus CY018, an endophytic fungus in Cynodon dactylon as a versatile producer of new and bioactive metabolites. J. Biotechnol. 2004, 114, 279–287; https://doi.org/10.1016/j.jbiotec.2004.07.008.Suche in Google Scholar

7. Frisvad, J. C., Rank, C., Nielsen, K. F., Larsen, T. O. Metabolomics of Aspergillus fumigatus. Med. Mycol. J. 2009, 47, S53–S71; https://doi.org/10.1080/13693780802307720.Suche in Google Scholar

8. Yang, Y., Yan, Y. M., Wei, W., Luo, J., Zhang, L. S., Zhou, X. J., Wang, P. C., Yang, Y. X., Cheng, Y. X. Anthraquinone derivatives from Rumex plants and endophytic Aspergillus fumigatus and their effects on diabetic nephropathy. Bioorg. Med. Chem. Lett. 2013, 23, 3905–3909; https://doi.org/10.1016/j.bmcl.2013.04.059.Suche in Google Scholar
Received: 2021-10-19
Accepted: 2021-12-02
Published Online: 2022-01-04
Published in Print: 2022-02-23

© 2021 Bao-Long Lai et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of (E)-7-hydroxy-2-((6-methoxypyridin-3-yl)methylene)-3, 4-dihydronaphthalen-1(2H)-one, C17H15NO3
  4. Crystal structure of (E)-7-methoxy-2-((2-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1 (2H)-one, C18H17NO3
  5. The crystal structure of N 6,N 6′-di(pyridin-2-yl)-[2,2′-bipyridine]-6,6′-diamine, C20H16N6
  6. The crystal structure of {N 1,N 2-bis[2,4-dimethyl-6-(4-(tert-butyl)phenyl)(phenyl)methyl]acenaphthylene-1,2-diimino-κ2 N, N′}-dibromido-nickel(II) – dichloromethane(1/2), C64H64Br2Cl4N2Ni
  7. Synthesis and crystal structure of nonacarbonyltris[(2-thia-1,3,5-triaza-7-phosphatricylco[3.3.1.1]decane-κ1 P)-2,2-dioxide]triruthenium(0) – acetonitrile (7/6), C25.71H32.57N9.86O15P3S3Ru3
  8. A new polymorph of 1-(4-nitrophenyl)-1H-benzimidazole (C13H9N3O2)
  9. The crystal structure of 2,2′-((1E,1′E)-(naphthalene-2,3 diylbis(azanylylidene)) bis(methanylylidene))bis(4-methylphenol), C26H22N2O2
  10. The crystal structure of bis(μ2-iodido)-bis(η6-benzene)-bis(iodido)-diosmium(II), C12H12I4Os2
  11. Redetermination of the crystal structure of bis{hydridotris(3,5-dimethylpyrazol-1-yl-κN 3)borato}copper(II), C30H44B2CuN12
  12. Crystal structure of (E)-3-((4-(tert-butyl)phenyl)thio)-4-hydroxypent-3-en-2-one, C15H20O2S
  13. Crystal structure of 2,2′-(p-tolylazanediyl)bis(1-phenylethan-1-one), C23H21NO2
  14. Redetermination of the crystal structure of the crystal sponge the poly[tetrakis(μ3-2,4,6-tris(pyridin-4-yl)-1,3,5-triazine)-dodecaiodidohexazinc(II) nitrobenzene solvate], C72H48I12N24Zn6⋅10(C6H5NO2)
  15. Crystal structure of (4′E)-6′-(diethylamino)-2-[(E)-[(6-methylpyridin-2-yl)methylidene]amino]-4′-{2-[(2E)-1,3,3-trimethyl-2,3-dihydro-1H-indol-2-ylidene]ethylidene}-1′,2,2′,3,3′,4′-hexahydrospiro[isoindole-1,9′-xanthene]-3-one, C44H45N5O2
  16. Crystal structure of (E)-7-fluoro-2-(3-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C17H12F2O1
  17. Crystal structure of tetrabutylammonium sulfanilate – 1-(diaminomethylene)thiourea (1/2)
  18. Crystal structure of [2,2′-{azanediyl)bis[(propane-3,1-diyl)(azanylylidene)methylylidene]} bis(3,5-dichlorophenolato)-κ2O,O′]-isothiocyanato-κN-iron(III), C21H19Cl4FeN4O2S
  19. Crystal structure of (4-chlorophenyl)(4-hydroxyphenyl)methanone, C13H9ClO2
  20. Crystal structure of 6,6′-((pentane-1,3-diylbis(azaneylylidene))bis(methaneylylidene))bis(2,4-dibromolphenolato-κ4 N,N′,O,O′)copper(II),) C19H16Br4CuN2O2
  21. Chlorido-(2,2′-(ethane-bis(5-methoxyphenolato))-κ4 N,N′,O,O′)manganese(III) monohydrate, C19H18Cl2CuN2O2
  22. Crystal structure of 2,6-di-tert-butyl-4-(4-methoxybenzylidene)cyclohexa-2,5-dien-1-one, C22H28O2
  23. Crystal structure of [6,6′-(((2,2-dimethylpropane-1,3-diyl)bis(azanylylidene))bis(methanylylidene))bis(2-chlorophenolato)-κ4N,N′,O,O′]copper(II)
  24. Crystal structure of 2-chloro-3-((thiophen-2-ylmethyl)amino)naphthalene-1,4-dione, C30H20O4N2Cl2S2
  25. Crystal structure of bis{hydridotris(3-trifluoromethyl-5-methylpyrazolyl-1-yl)borato-κN 3}manganese(II), C30H26B2F18MnN12
  26. Crystal structure of 1-(2-methylphenyl)-2-(2-methylbenzo[b]thienyl)-3,3,4,4,5,5-hexafluorocyclopent-ene, C21H14F6S
  27. Crystal structure of 2-(3-((carbamimidoylthio)methyl)benzyl)isothiouronium hexafluorophosphate monohydrate, C10H17F6N4OPS2
  28. Crystal structure of 4,5-diiodo-1,3-dimesityl-1H-1,2,3-triazol-3-ium chloride – chloroform (1/1), C21H23Cl4I2N3
  29. Crystal structure of azido-k1 N-{6,6′-((((methylazanediyl)bis(propane-3,1-diyl))bis(azanylylidene))bis(methanylylidene))bis(2,4-dibromophenolato)k5 N,N′,N″,O,O′}cobalt(III)-methanol (1/1)), C21H23Br4CoN6O3
  30. The crystal structure of 2-(4-((carbamimidoylthio)methyl)benzyl)isothiouronium hexafluorophosphate monohydrate, C10H17F6N4OPS2
  31. Crystal structure of 1,1′-(methane-1,1-diyl)bis(3-methyl-1H-imidazol-3-ium) bis(hexafluoridophosphate), C9H14F12N4P2
  32. Crystal structure of (4′E)-6′-(diethylamino)-2-[(E)-[(pyren-1-yl)methylidene]amino]-4′-{2-[(2E)-1,3,3-trimethyl-2,3-dihydro-1H-indol-2-ylidene]ethylidene}-1′,2,2′,3,3′,4′-hexahydrospiro[isoindole-1,9′-xanthene]-3-one, C54H48N4O2
  33. Crystal structure of poly[bis(μ2-2,6-bis(1-imidazoly)pyridine-κ2 N,N′)-bis(thiocyanato-κ1 N)copper(II)] dithiocyanate, C24H18CuN12S2
  34. Cones with a three-fold symmetry constructed from three hydrogen bonded theophyllinium cations that coat [FeCl4]− anions in the crystal structure of tris(theophyllinium) bis(tetrachloridoferrate(III)) chloride trihydrate, C21H33Cl9Fe2N12O9
  35. Crystal structure of 14-O-[(4-(4-hydroxypiperidine-1-yl)-6-methylpyrimidine-2-yl)thioacetyl]-mutilin monohydrate, C32H49N3O6S
  36. The crystal structure of (E)-3-chloro-2-(2-(4-methylbenzylidene)hydrazinyl)pyridine, C13H12ClN3
  37. The crystal structure of 4-phenyl-4-[2-(pyridine-4-carbonyl)hydrazinylidene]butanoic acid, C16H15N3O3
  38. The crystal structure of 6-amino-5-carboxypyridin-1-ium pentaiodide monohydrate C6H9I5N2O3
  39. Crystal structure of bis(μ3-oxido)-bis(μ2-2-formylbenzoato-k2O:O′)-bis(2-(dimethoxymethyl)-benzoato-κO)-oktakismethyl-tetratin(IV)
  40. Crystal structure of 2-((E)-(((E)-2-hydroxy-4-methylbenzylidene) hydrazineylidene)methyl)-4-methylphenol, C16H16N2O2
  41. Crystal structure of (E)-amino(2-((5-methylfuran-2-yl)methylene)hydrazinyl) methaniminium nitrate monohydrate, C14H26N10O10
  42. The crystal structure of N′-(2-chloro-6-hydroxybenzylidene)thiophene-2-carbohydrazide monohydrate, C12H11ClN2O3S
  43. Crystal structure of catena-poly[(μ2-1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol)-κ2N:N′)-bis(4-bromobenzoate-κ1O)zinc(II)], C64H44Br4N8O8Zn2
  44. The crystal structure of catena-poly[(1-(4-carboxybenzyl)pyridin-1-ium-4-carboxylato-κ1O)-(μ2-oxalato-κ4 O:O′:O″:O‴)dioxidouranium(VI)], C16H11NO10U
  45. Crystal structure of 3-allyl-4-(2-bromoethyl)-5-(4-methoxyphenyl)-2-phenylfuran, C22H21BrO2
  46. Halogen bonds in the crystal structure of 4,3′:5′,4″-terpyridine — 1,3-diiodotetrafluorobenzene (1/1), C21H11F4I2N3
  47. Crystal structure of 2-(1H-indol-3-yl)ethan-1-aminium 2-(4-acetylphenoxy)acetate, C20H22N2O4
  48. Chalcogen bonds in the crystal structure of 4,7-dibromo-2,1,3-benzoselenadiazole, C6H2Br2N2Se
  49. The crystal structure of 1,4-bis((1H-benzimidazol-2-yl)methyl)-piperazine-2,5-dione dihydrate, C20H22N6O4
  50. The crystal structure of C19H20O8
  51. The crystal structure of KNa3Te8O18·5H2O exhibiting a ∞2[Te4O9]2− layer
  52. Erratum
  53. Erratum to: Crystal structure of (Z)-3-(6-bromo-1H-indol-3-yl)-1,3-diphenylprop-2-en-1-one, C23H16BrNO
https://doi.org/10.1515/ncrs-2021-0405
Creative Commons
BY 4.0

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of (E)-7-hydroxy-2-((6-methoxypyridin-3-yl)methylene)-3, 4-dihydronaphthalen-1(2H)-one, C17H15NO3
  4. Crystal structure of (E)-7-methoxy-2-((2-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1 (2H)-one, C18H17NO3
  5. The crystal structure of N 6,N 6′-di(pyridin-2-yl)-[2,2′-bipyridine]-6,6′-diamine, C20H16N6
  6. The crystal structure of {N 1,N 2-bis[2,4-dimethyl-6-(4-(tert-butyl)phenyl)(phenyl)methyl]acenaphthylene-1,2-diimino-κ2 N, N′}-dibromido-nickel(II) – dichloromethane(1/2), C64H64Br2Cl4N2Ni
  7. Synthesis and crystal structure of nonacarbonyltris[(2-thia-1,3,5-triaza-7-phosphatricylco[3.3.1.1]decane-κ1 P)-2,2-dioxide]triruthenium(0) – acetonitrile (7/6), C25.71H32.57N9.86O15P3S3Ru3
  8. A new polymorph of 1-(4-nitrophenyl)-1H-benzimidazole (C13H9N3O2)
  9. The crystal structure of 2,2′-((1E,1′E)-(naphthalene-2,3 diylbis(azanylylidene)) bis(methanylylidene))bis(4-methylphenol), C26H22N2O2
  10. The crystal structure of bis(μ2-iodido)-bis(η6-benzene)-bis(iodido)-diosmium(II), C12H12I4Os2
  11. Redetermination of the crystal structure of bis{hydridotris(3,5-dimethylpyrazol-1-yl-κN 3)borato}copper(II), C30H44B2CuN12
  12. Crystal structure of (E)-3-((4-(tert-butyl)phenyl)thio)-4-hydroxypent-3-en-2-one, C15H20O2S
  13. Crystal structure of 2,2′-(p-tolylazanediyl)bis(1-phenylethan-1-one), C23H21NO2
  14. Redetermination of the crystal structure of the crystal sponge the poly[tetrakis(μ3-2,4,6-tris(pyridin-4-yl)-1,3,5-triazine)-dodecaiodidohexazinc(II) nitrobenzene solvate], C72H48I12N24Zn6⋅10(C6H5NO2)
  15. Crystal structure of (4′E)-6′-(diethylamino)-2-[(E)-[(6-methylpyridin-2-yl)methylidene]amino]-4′-{2-[(2E)-1,3,3-trimethyl-2,3-dihydro-1H-indol-2-ylidene]ethylidene}-1′,2,2′,3,3′,4′-hexahydrospiro[isoindole-1,9′-xanthene]-3-one, C44H45N5O2
  16. Crystal structure of (E)-7-fluoro-2-(3-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C17H12F2O1
  17. Crystal structure of tetrabutylammonium sulfanilate – 1-(diaminomethylene)thiourea (1/2)
  18. Crystal structure of [2,2′-{azanediyl)bis[(propane-3,1-diyl)(azanylylidene)methylylidene]} bis(3,5-dichlorophenolato)-κ2O,O′]-isothiocyanato-κN-iron(III), C21H19Cl4FeN4O2S
  19. Crystal structure of (4-chlorophenyl)(4-hydroxyphenyl)methanone, C13H9ClO2
  20. Crystal structure of 6,6′-((pentane-1,3-diylbis(azaneylylidene))bis(methaneylylidene))bis(2,4-dibromolphenolato-κ4 N,N′,O,O′)copper(II),) C19H16Br4CuN2O2
  21. Chlorido-(2,2′-(ethane-bis(5-methoxyphenolato))-κ4 N,N′,O,O′)manganese(III) monohydrate, C19H18Cl2CuN2O2
  22. Crystal structure of 2,6-di-tert-butyl-4-(4-methoxybenzylidene)cyclohexa-2,5-dien-1-one, C22H28O2
  23. Crystal structure of [6,6′-(((2,2-dimethylpropane-1,3-diyl)bis(azanylylidene))bis(methanylylidene))bis(2-chlorophenolato)-κ4N,N′,O,O′]copper(II)
  24. Crystal structure of 2-chloro-3-((thiophen-2-ylmethyl)amino)naphthalene-1,4-dione, C30H20O4N2Cl2S2
  25. Crystal structure of bis{hydridotris(3-trifluoromethyl-5-methylpyrazolyl-1-yl)borato-κN 3}manganese(II), C30H26B2F18MnN12
  26. Crystal structure of 1-(2-methylphenyl)-2-(2-methylbenzo[b]thienyl)-3,3,4,4,5,5-hexafluorocyclopent-ene, C21H14F6S
  27. Crystal structure of 2-(3-((carbamimidoylthio)methyl)benzyl)isothiouronium hexafluorophosphate monohydrate, C10H17F6N4OPS2
  28. Crystal structure of 4,5-diiodo-1,3-dimesityl-1H-1,2,3-triazol-3-ium chloride – chloroform (1/1), C21H23Cl4I2N3
  29. Crystal structure of azido-k1 N-{6,6′-((((methylazanediyl)bis(propane-3,1-diyl))bis(azanylylidene))bis(methanylylidene))bis(2,4-dibromophenolato)k5 N,N′,N″,O,O′}cobalt(III)-methanol (1/1)), C21H23Br4CoN6O3
  30. The crystal structure of 2-(4-((carbamimidoylthio)methyl)benzyl)isothiouronium hexafluorophosphate monohydrate, C10H17F6N4OPS2
  31. Crystal structure of 1,1′-(methane-1,1-diyl)bis(3-methyl-1H-imidazol-3-ium) bis(hexafluoridophosphate), C9H14F12N4P2
  32. Crystal structure of (4′E)-6′-(diethylamino)-2-[(E)-[(pyren-1-yl)methylidene]amino]-4′-{2-[(2E)-1,3,3-trimethyl-2,3-dihydro-1H-indol-2-ylidene]ethylidene}-1′,2,2′,3,3′,4′-hexahydrospiro[isoindole-1,9′-xanthene]-3-one, C54H48N4O2
  33. Crystal structure of poly[bis(μ2-2,6-bis(1-imidazoly)pyridine-κ2 N,N′)-bis(thiocyanato-κ1 N)copper(II)] dithiocyanate, C24H18CuN12S2
  34. Cones with a three-fold symmetry constructed from three hydrogen bonded theophyllinium cations that coat [FeCl4]− anions in the crystal structure of tris(theophyllinium) bis(tetrachloridoferrate(III)) chloride trihydrate, C21H33Cl9Fe2N12O9
  35. Crystal structure of 14-O-[(4-(4-hydroxypiperidine-1-yl)-6-methylpyrimidine-2-yl)thioacetyl]-mutilin monohydrate, C32H49N3O6S
  36. The crystal structure of (E)-3-chloro-2-(2-(4-methylbenzylidene)hydrazinyl)pyridine, C13H12ClN3
  37. The crystal structure of 4-phenyl-4-[2-(pyridine-4-carbonyl)hydrazinylidene]butanoic acid, C16H15N3O3
  38. The crystal structure of 6-amino-5-carboxypyridin-1-ium pentaiodide monohydrate C6H9I5N2O3
  39. Crystal structure of bis(μ3-oxido)-bis(μ2-2-formylbenzoato-k2O:O′)-bis(2-(dimethoxymethyl)-benzoato-κO)-oktakismethyl-tetratin(IV)
  40. Crystal structure of 2-((E)-(((E)-2-hydroxy-4-methylbenzylidene) hydrazineylidene)methyl)-4-methylphenol, C16H16N2O2
  41. Crystal structure of (E)-amino(2-((5-methylfuran-2-yl)methylene)hydrazinyl) methaniminium nitrate monohydrate, C14H26N10O10
  42. The crystal structure of N′-(2-chloro-6-hydroxybenzylidene)thiophene-2-carbohydrazide monohydrate, C12H11ClN2O3S
  43. Crystal structure of catena-poly[(μ2-1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol)-κ2N:N′)-bis(4-bromobenzoate-κ1O)zinc(II)], C64H44Br4N8O8Zn2
  44. The crystal structure of catena-poly[(1-(4-carboxybenzyl)pyridin-1-ium-4-carboxylato-κ1O)-(μ2-oxalato-κ4 O:O′:O″:O‴)dioxidouranium(VI)], C16H11NO10U
  45. Crystal structure of 3-allyl-4-(2-bromoethyl)-5-(4-methoxyphenyl)-2-phenylfuran, C22H21BrO2
  46. Halogen bonds in the crystal structure of 4,3′:5′,4″-terpyridine — 1,3-diiodotetrafluorobenzene (1/1), C21H11F4I2N3
  47. Crystal structure of 2-(1H-indol-3-yl)ethan-1-aminium 2-(4-acetylphenoxy)acetate, C20H22N2O4
  48. Chalcogen bonds in the crystal structure of 4,7-dibromo-2,1,3-benzoselenadiazole, C6H2Br2N2Se
  49. The crystal structure of 1,4-bis((1H-benzimidazol-2-yl)methyl)-piperazine-2,5-dione dihydrate, C20H22N6O4
  50. The crystal structure of C19H20O8
  51. The crystal structure of KNa3Te8O18·5H2O exhibiting a ∞2[Te4O9]2− layer
  52. Erratum
  53. Erratum to: Crystal structure of (Z)-3-(6-bromo-1H-indol-3-yl)-1,3-diphenylprop-2-en-1-one, C23H16BrNO
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 9.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2021-0405/html
Button zum nach oben scrollen